SNY
October 25, 2024 - AI Summary
Undervalued by 60.2% based on the discounted cash flow analysis.
Market cap | $136.30 Billion |
---|---|
Enterprise Value | $151.65 Billion |
Dividend Yield | $2.04 (3.00865573248845%) |
Earnings per Share | $2.15 |
Beta | 0.42 |
Outstanding Shares | 2,497,600,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 15.58 |
---|---|
PEG | 135.67 |
Price to Sales | 1.97 |
Price to Book Ratio | 1.84 |
Enterprise Value to Revenue | 2.19 |
Enterprise Value to EBIT | 9.82 |
Enterprise Value to Net Income | 18 |
Total Debt to Enterprise | 0.15 |
Debt to Equity | 0.3 |
No data
No data
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the c...